Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia

International Psychogeriatrics

Volumn 21, Issue 3, 2009, Pages 485-493

  Nijk, Renate M ^a,b   Zuidema, Sytse U ^a   Koopmans, Raymond T C M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Van Neynselgroep   (Netherlands)

Author keywords

Antidepressants; Antipsychotics; Behavioral and psychological symptoms of dementia; Dementia; Neuropsychiatric symptoms; Nursing home; Psychotropic drug use

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT; HYPNOTIC SEDATIVE AGENT;

ADULT; AGE; AGED; AGITATION; ARTICLE; DEMENTIA; DEPRESSION; DISEASE SEVERITY; DRUG USE; FEMALE; GENDER; GLOBAL DETERIORATION SCALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; NURSING HOME PATIENT; PRESCRIPTION; PSYCHOSIS; RATING SCALE; BEHAVIOR; COGNITIVE DEFECT; COMPARATIVE STUDY; DRUG COMBINATION; DRUG UTILIZATION; NURSING HOME; PSYCHOLOGICAL ASPECT; RISK FACTOR; SEX DIFFERENCE; STATISTICS;

AGE FACTORS; AGED; ANTI-ANXIETY AGENTS; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BEHAVIORAL SYMPTOMS; COGNITION DISORDERS; DEMENTIA; DRUG THERAPY, COMBINATION; DRUG UTILIZATION; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; NETHERLANDS; NURSING HOMES; PSYCHOTROPIC DRUGS; RISK FACTORS; SEX FACTORS;

EID: 67649099444     PISSN: 10416102     EISSN: 1741203X     Source Type: Journal    
DOI: 10.1017/S1041610209008916     Document Type: Article

References (30)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: Amercian Psychiatric Association.
2. Ballard, C. et al. (2008). A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD Trial). PLoS Medicine, 5, 587-599. (Pubitemid 351649258)
3. Brodaty, H., Draper, B., Saab, D., Low, L. F., Richards, V., Paton, H. and Lie, D. (2001). Psychosis, depression and behavioural disturbances in Sydney nursing home residents: prevalence and predictors. International Journal of Geriatric Psychiatry, 16, 504-512. (Pubitemid 32492385)
4. Cohen-Mansfield, J. and Billig, N. (1986). Agitated behaviors in the elderly. I. A conceptual review. Journal of the American Geriatrics Society, 34, 711-721. (Pubitemid 16028163)
5. de Jonghe, J. F. and Kat, M. G. (1996). Factor structure and validity of the Dutch version of the Cohen-Mansfield Agitation Inventory (CMAI-D). Journal of the American Geriatrics Society, 44, 888-889.
6. Draper, B. et al. (2001). Use of psychotropics in Sydney nursing homes: associations with depression, psychosis, and behavioral disturbances. International Psychogeriatrics, 3, 107-120. (Pubitemid 32411154)
7. Fossey, J. et al. (2006). Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: cluster randomised trial. BMJ, 332, 756-761. (Pubitemid 44365651)
8. Kat, M. G., de Jonghe, J. F., Aalten, P., Kalisvaart, C. J., Droes, R. M. and Verhey, F. R. (2002). Neuropsychiatric symptoms of dementia: psychometric aspects of the Dutch Neuropsychiatric Inventory (NPI). Tijdschrift voor Gerontologie en Geriatrie, 33, 150-155 (in Dutch).
9. Kim, H. and Whall, A. L. (2006). Factors associated with psychotropic drug usage among nursing home residents with dementia. Nursing Research, 55, 252-258. (Pubitemid 44503656)
10. Lindesay, J., Matthews, R. and Jagger, C. (2003). Factors associated with antipsychotic drug use in residential care: changes between 1990 and 1997. International Journal of Geriatric Psychiatry, 18, 511-519. (Pubitemid 36763654)
11. Lövheim, H., Sandman, P. O., Kallin, K., Karlsson, S. and Gustafson, Y. (2006). Relationship between antipsychotic drug use and behavioral and psychological symptoms of dementia in old people with cognitive impairment living in geriatric care. International Psychogeriatrics, 18, 713-726. (Pubitemid 44623003)
12. Lyketsos, C. G., Steinberg, M., Tschanz, J. T., Norton, M. C., Steffens, D. C. and Breitner, J. C. (2000). Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging, American Journal of Psychiatry, 157, 708-714. (Pubitemid 30249648)
13. Macdonald, A. J., Carpenter, G. I., Box, O., Roberts, A. and Sahu, S. (2002). Dementia and use of psychotropic medication in non-"Elderly Mentally Infirm" nursing homes in South East England. Age and Ageing, 31, 58-64.
14. Nordic Council on Medicines. Guideline for ATC Classification (1990). Unpublished manuscript. Oslo: WHO Collaborating Center for Drugs Statistics Methodology.
15. Pitkälä, K.H., Laurila, J. V., Strandberg, T. E. and Tilvis, R. S. (2004). Behavioral symptoms and the administration of psychotropic drugs to aged patients with dementia in nursing homes and in acute geriatric wards. International Psychogeriatrics, 16, 61-74.
16. Ramadan, F. H., Naughton, B. J. and Prior, R. (2003). Correlates of behavioral disturbances and pattern of psychotropic medication use in five skilled nursing facilities. Journal of Geriatric Psychiatry and Neurology, 16, 8-14.
17. Reisberg, B., Ferris, S. H., de Leon, M. J. and Crook, T. (1982). The Global Deterioration Scale for assessment of primary degenerative dementia. American Journal of Psychiatry, 139, 1136-1139. (Pubitemid 12051593)
18. Rochon, P. A. et al. (2008). Antipsychotic therapy and short-term serious events in older adults with dementia. Archives of Internal Medicine, 168, 1090-1096.
19. Schneider, L. S., Dagerman, K. S. and Insel, P. (2005). Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials. JAMA, 294, 1934-1943.
20. Schneider, L. S. et al. (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. New England Journal of Medicine, 355, 1525-1538. (Pubitemid 44547805)
21. Selbaek, G., Kirkevold, O. and Engedal, K. (2007). The prevalence of psychiatric symptoms and behavioural disturbances and the use of psychotropic drugs in Norwegian nursing homes. International Journal of Geriatric Psychiatry, 22, 843-849. (Pubitemid 47455265)
22. Sink, K. M., Holden, K. F. and Yaffe, K. (2005). Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA, 293, 596-608. (Pubitemid 40171242)
23. van Gool, W. A., Stam, C. J., Steenhoek, A. and Hagemeijer, A. (2006). The practice guideline "Diagnosis and pharmaceutical treatment of dementia". Nederlands Tijdschrift van Geneeskunde, 150, 839-843 (in Dutch).
24. van Iersel, M. B., Zuidema, S. U., Koopmans, R. T. C. M., Verhey, F. R. J. and Olde Rikkert, M. G. M. (2005). Antipsychotics for behavioural and psychological problems in elderly people with dementia: a systematic review of adverse events. Drugs and Aging, 22, 845-858.
25. Ypma-Bakker, M. et al. (2002). Guideline problem behaviour. Tijdschrift voor verpleeghuisgeneeskunde, 26, 5-31 (in Dutch).
26. World Health Organization (2005). Anatomical Therapeutical Chemical (ATC), Classification Index Including Daily Doses (DDD) for Plain Substances. Oslo: World Health Organization Collaborating Center for Drug Statistics Methodology.
27. Zuidema, S. U., Derksen, E., Verhey, F. R. J. and Koopmans, R. T. (2007a). Prevalence of neuropsychiatric symptoms in a large sample of Dutch nursing home patients with dementia. International Journal of Geriatric Psychiatry. 22, 632-1238 (Pubitemid 47180375)
28. Zuidema, S., Koopmans, R. and Verhey, F. (2007b). Prevalence and predictors of neuropsychiatric symptoms in cognitively impaired nursing home patients. Journal of Geriatric Psychiatry and Neurology, 20, 41-49. (Pubitemid 46233618)
29. Zuidema, S. U., de Jonghe, J. F., Verhey, F. R. and Koopmans, R. T. (2007c). Agitation in Dutch institutionalized patients with dementia: factor analysis of the Dutch version of the Cohen-Mansfield Agitation Inventory. Dementia and Geriatric Cognitive Disorders, 23, 35-41.
30. Zuidema, S. U., de Jonghe, J. F., Verhey, F. R., and Koopmans, R. T. (2007d). Neuropsychiatric symptoms in nursing home patients: factor structure invariance of the Dutch nursing home version of the neuropsychiatric inventory in different stages of dementia. Dementia and Geriatric Cognitive Disorders, 24, 169-176.